BLUE
Profile banner
AF
Adam Feuerstein
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Formerly verified on that other platform. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
1.2k followers170 following12 posts
AFadamfeuerstein.bsky.social

Data-DXd may turn out to benefit lung cancerpatients, but $AZN and Daiichi Sankyo disrespect the participants in their clinical trial by referring to side-effect related deaths as "Grade 5 events."

0

Profile banner
AF
Adam Feuerstein
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Formerly verified on that other platform. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
1.2k followers170 following12 posts